sales@theinsightpartners.com
+1-646-491-9876 +44-20-8125-4005

Asia Pacific Rnai Therapeutics Market Scope And Analysis

  • Report Code : TIPRE00015147
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 133
Buy Now

Asia Pacific RNAi Therapeutics Market Scope, Growth, Size and Share by 2027

Buy Now

Asia Pacific RNAi Therapeutics Market Report Asia Pacific RNAi Therapeutics Market Size and Share Asia Pacific RNAi Therapeutics Market Scope and Analysis

Asia Pacific RNAi Therapeutics Market Report Scope

Report Attribute Details
Market size in 2019 US$ 107.63 Million
Market Size by 2027 US$ 218.64 Million
Global CAGR (2020 - 2027) 9.3%
Historical Data 2017-2018
Forecast period 2020-2027
Segments Covered By Molecule Type
  • Small Interfering RNAs
  • MicroRNA
By Application
  • Genetic Disorders
  • Oncology
  • Neurodegenerative Disorders
  • Cardiovascular
  • Respiratory Disorders
  • Infectious Diseases
  • Renal Diseases
By Route of Administration
  • Intradermal Injections
  • Pulmonary Delivery
  • Intravenous Injections
  • Intraperitoneal Injections
By End User
  • Diagnostic Laboratories
  • Research and Academic Laboratories
  • Hospitals
Regions and Countries Covered Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
Market leaders and key company profiles
  • Benitec Biopharma
  • Olix Pharmaceuticals Inc
  • GlaxoSmithKline plc
  • Alnylam Pharmaceuticals Inc
  • Arrowhead Pharmaceuticals Inc
    		•